ABM Asian Biomaterials Group

Wuhan Asian Biomaterials Co., Ltd. is a core backbone enterprise of medical devices in Biolake, Wuhan, a "Golden Seed Enterprise" recognized by the Listed Company Office of Hubei Province, and a "Gazelle Enterprise" of Wuhan. It owns four holding companies and three independent business divisions, including two national high-tech enterprises. Asian Biomaterials Group possesses internationally first-class GMP Class 100,000 cleanroom production facilities. Its new product base building has a total area of more than 10,000 square meters, and houses the "International Joint Laboratory for High-end Biomaterial Devices" and two provincial and ministerial-level R&D platforms — the Hubei Provincial Institute of Bioactive Material Devices Technology and the Hubei Provincial Engineering Research Center for Oral and Maxillofacial Medical Devices and Equipment. It is Asia's largest production base for calcium-phosphate bioactive materials, and has established overseas collaborative R&D centers and bases in the United States, Australia, and South Korea. The company has undertaken major national key projects such as the National Key R&D Program, the National "863" High-Tech Development Plan, the National Science and Technology Support Program, and the Intergovernmental International Cooperation Program of the Ministry of Science and Technology, representing the national level of technological innovation and commercialization in the field of high-end biomaterial devices. The company has the R&D and production capacity for more than 10 types of medical material and device products, including the highly active bone repair material device series (Yougesheng®, Jingesheng®, Ruigesheng®), the dental restorative material product series, and the Yafukang® wound repair material product series. Among these, 3 are world-first products, 5 are listed as major strategic products of the National Key R&D Program, and 2 are listed as "breakthrough" high-end medical device innovative products in the big health field of Hubei Province. It is a representative high-tech enterprise in the field of independent innovation of medical devices in China. The company has an internationally top-level R&D team, including 1 Chairman of the TERMIS Asia-Pacific Chapter, 1 Fellow of the International Union of Societies for Biomaterials Science and Engineering (IUSBSE Fellow) and Chief Scientist of the National Key R&D Program, 1 Academician of the Chinese Academy of Sciences, 1 Member of the National Academy of Engineering of the United States, 1 "Young Top-notch Talent" of the Ten Thousand Talents Plan of the Central Organization Department, 2 selected candidates of the "Young Talent Support Project" of the China Association for Science and Technology, 3 "3551 Talents" of Wuhan, as well as a group of high-level postdoctoral, doctoral, and master's talents. ABM Asian Biomaterials Company adheres to the philosophy of "International Standards, Excellent Quality, World Brand" and takes it as its mission to continuously provide health products that satisfy the people, and is becoming an important supporting force leading the industry's technological innovation and high-quality development.